BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Miranda J, Brazil JC, Morris AH, Parkos CA, Quiros M, Nusrat A. Maresin-2 promotes mucosal repair and has therapeutic potential when encapsulated in thermostable nanoparticles. Proc Natl Acad Sci U S A 2023;120:e2218162120. [PMID: 36669099 DOI: 10.1073/pnas.2218162120] [Reference Citation Analysis]
2 Choi MY, Cook NR, Kotler G, Serhan CN, Tatituri R, Costenbader KH. Fish oil supplementation in patients with and without systemic lupus erythematosus: targeting pro-inflammatory and pro-resolving lipid mediators. Clin Exp Rheumatol 2022;40:2196-7. [PMID: 35894061 DOI: 10.55563/clinexprheumatol/xxr27t] [Reference Citation Analysis]
3 Yamaguchi A, Botta E, Holinstat M. Eicosanoids in inflammation in the blood and the vessel. Front Pharmacol 2022;13:997403. [PMID: 36238558 DOI: 10.3389/fphar.2022.997403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fattori V, Zaninelli TH, Ferraz CR, Brasil-Silva L, Borghi SM, Cunha JM, Chichorro JG, Casagrande R, Verri WA Jr. Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release. Neuropharmacology 2022;216:109189. [PMID: 35820471 DOI: 10.1016/j.neuropharm.2022.109189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Reid MM, Obenaus A, Mukherjee PK, Khoutorova L, Roque CR, Petasis NA, Oria RB, Belayev L, Bazan NG. Synergistic Neuroprotection by a PAF Antagonist Plus a Docosanoid in Experimental Ischemic Stroke: Dose-Response and Therapeutic Window. J Stroke Cerebrovasc Dis 2022;31:106585. [PMID: 35717719 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106585] [Reference Citation Analysis]
6 Hasan Khan M, Pathak S, Yadav U, Rochlani Y, Aronow WS. Hypertension in Cancer Survivors. Curr Hypertens Rep. [DOI: 10.1007/s11906-022-01208-2] [Reference Citation Analysis]
7 Liotti F, Marotta M, Melillo RM, Prevete N. The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression. Cancers 2022;14:3333. [DOI: 10.3390/cancers14143333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Frank Lee C, Brown CE, Nielsen AJ, Kim C, Livne-Bar I, Parsons PJ, Boldron C, Autelitano F, Weaver DF, Sivak JM, Reed MA. A Stereocontrolled Total Synthesis of Lipoxin B4 and its Biological Activity as a Pro-Resolving Lipid Mediator of Neuroinflammation. Chemistry 2022;28:e202200360. [PMID: 35491534 DOI: 10.1002/chem.202200360] [Reference Citation Analysis]
9 Radbakhsh S, Katsiki N, Santos RD, Mikhailidis DP, Mantzoros CS, Sahebkar A. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation. Metabolism 2022;:155211. [PMID: 35533891 DOI: 10.1016/j.metabol.2022.155211] [Reference Citation Analysis]
10 Kotlyarov S, Kotlyarova A. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. Int J Mol Sci 2022;23. [PMID: 35563200 DOI: 10.3390/ijms23094808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Salazar J, Pirela D, Nava M, Castro A, Angarita L, Parra H, Durán-Agüero S, Rojas-Gómez DM, Galbán N, Añez R, Chacín M, Diaz A, Villasmil N, De Sanctis JB, Bermúdez V. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int J Mol Sci 2022;23:3133. [PMID: 35328553 DOI: 10.3390/ijms23063133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Duecker RP, De Mir Messa I, Jerkic S, Kochems A, Gottwald G, Moreno‐galdó A, Rosewich M, Gronau L, Zielen S, Geburtig‐chiocchetti A, Kreyenberg H, Schubert R. Epigenetic regulation of inflammation by microRNAs in post‐infectious bronchiolitis obliterans. Clin & Trans Imm 2022;11. [DOI: 10.1002/cti2.1376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kolawole OR, Kashfi K. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase. Int J Mol Sci 2022;23:1432. [PMID: 35163356 DOI: 10.3390/ijms23031432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
14 Wang Z, Yang B. Polypharmacology in Clinical Applications—Anti-inflammation Polypharmacology. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_11] [Reference Citation Analysis]
15 Tavares LP, Galvão I, Ferrero MR. Novel Immunomodulatory Therapies for Respiratory Pathologies. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00073-6] [Reference Citation Analysis]
16 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
17 Biringer RG. Endocannabinoid signaling pathways: beyond CB1R and CB2R. J Cell Commun Signal 2021;15:335-60. [PMID: 33978927 DOI: 10.1007/s12079-021-00622-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 de Fáveri C, Fermino PMP, Piovezan AP, Volpato LK. The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review. Int J Mol Sci 2021;22:4370. [PMID: 33922064 DOI: 10.3390/ijms22094370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Jin S, Sun S, Ling H, Ma J, Zhang X, Xie Z, Zhan N, Zheng W, Li M, Qin Y, Zhao H, Chen Y, Yang X, Wang J. Protectin DX restores Treg/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a. Cell Death Dis 2021;12:280. [PMID: 33723242 DOI: 10.1038/s41419-021-03562-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
20 Fattori V, Ferraz CR, Rasquel-Oliveira FS, Verri WA Jr. Neuroimmune communication in infection and pain: Friends or foes? Immunol Lett 2021;229:32-43. [PMID: 33248166 DOI: 10.1016/j.imlet.2020.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
22 Oppedisano F, Macrì R, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Bosco F, Nucera S, Caterina Zito M, Guarnieri L, Scarano F, Nicita C, Coppoletta AR, Ruga S, Scicchitano M, Mollace R, Palma E, Mollace V. The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection. Biomedicines 2020;8:E306. [PMID: 32854210 DOI: 10.3390/biomedicines8090306] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 19.7] [Reference Citation Analysis]
23 Biringer RG. The enzymology of human eicosanoid pathways: the lipoxygenase branches. Mol Biol Rep 2020;47:7189-207. [PMID: 32748021 DOI: 10.1007/s11033-020-05698-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000 2020;83:26-39. [PMID: 32385877 DOI: 10.1111/prd.12297] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 37.7] [Reference Citation Analysis]
25 Martinez RM, Fattori V, Saito P, Pinto IC, Rodrigues CCA, Melo CPB, Bussmann AJC, Staurengo-Ferrari L, Bezerra JR, Vignoli JA, Baracat MM, Georgetti SR, Verri WA Jr, Casagrande R. The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. Molecules 2020;25:E2953. [PMID: 32604968 DOI: 10.3390/molecules25122953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
26 Maisto R, Trotta MC, Petrillo F, Izzo S, Cuomo G, Alfano R, Hermenean A, Barcia JM, Galdiero M, Platania CBM, Bucolo C, D'Amico M. Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose. Front Pharmacol 2020;11:235. [PMID: 32210819 DOI: 10.3389/fphar.2020.00235] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
27 Sorrentino TA, Duong P, Bouchareychas L, Chen M, Chung A, Schaller MS, Oskowitz A, Raffai RL, Conte MS. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo. JVS Vasc Sci 2020;1:28-41. [PMID: 32550603 DOI: 10.1016/j.jvssci.2020.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
28 Emre C, Hjorth E, Bharani K, Carroll S, Granholm AC, Schultzberg M. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain. Brain Pathol 2020;30:614-40. [PMID: 31912564 DOI: 10.1111/bpa.12812] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
29 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 15.7] [Reference Citation Analysis]
30 Horio Y, Sogabe R, Shichiri M, Ishida N, Morimoto R, Ohshima A, Isegawa Y. Induction of a 5-lipoxygenase product by daidzein is involved in the regulation of influenza virus replication. J Clin Biochem Nutr 2020;66:36-42. [PMID: 32001954 DOI: 10.3164/jcbn.19-70] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
31 Hwang SM, Chung G, Kim YH, Park CK. The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration. Int J Mol Sci 2019;20:E5849. [PMID: 31766461 DOI: 10.3390/ijms20235849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
32 Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
33 Wang T, Zhang J, Tian J, Hu S, Wei R, Cui L. Low expression levels of plasma miR-141 are associated with susceptibility to gastric cancer. Oncol Lett 2019;18:629-36. [PMID: 31289535 DOI: 10.3892/ol.2019.10390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
34 Fattori V, Pinho-Ribeiro FA, Staurengo-Ferrari L, Borghi SM, Rossaneis AC, Casagrande R, Verri WA Jr. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect. Br J Pharmacol 2019;176:1728-44. [PMID: 30830967 DOI: 10.1111/bph.14647] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
35 Kutzner L, Rund KM, Ostermann AI, Hartung NM, Galano JM, Balas L, Durand T, Balzer MS, David S, Schebb NH. Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples. Front Pharmacol 2019;10:169. [PMID: 30899221 DOI: 10.3389/fphar.2019.00169] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
36 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
37 Bisicchia E, Sasso V, Molinari M, Viscomi MT. Plasticity of microglia in remote regions after focal brain injury. Semin Cell Dev Biol 2019;94:104-11. [PMID: 30703556 DOI: 10.1016/j.semcdb.2019.01.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Khozin-goldberg I, Sayanova O. Metabolic Engineering and Synthetic Biology Approaches to Enhancing Production of Long-Chain Polyunsaturated Fatty Acids in Microalgae. Grand Challenges in Algae Biotechnology 2019. [DOI: 10.1007/978-3-030-25233-5_7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Yang T, Terrando N. The Evolving Role of Specialized Pro-resolving Mediators in Modulating Neuroinflammation in Perioperative Neurocognitive Disorders. Adv Exp Med Biol 2019;1161:27-35. [PMID: 31562619 DOI: 10.1007/978-3-030-21735-8_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Pirault J, Bäck M. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease. Front Pharmacol 2018;9:1273. [PMID: 30487747 DOI: 10.3389/fphar.2018.01273] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 17.0] [Reference Citation Analysis]
41 Saito P, Melo CPB, Martinez RM, Fattori V, Cezar TLC, Pinto IC, Bussmann AJC, Vignoli JA, Georgetti SR, Baracat MM, Verri WA Jr, Casagrande R. The Lipid Mediator Resolvin D1 Reduces the Skin Inflammation and Oxidative Stress Induced by UV Irradiation in Hairless Mice. Front Pharmacol 2018;9:1242. [PMID: 30429790 DOI: 10.3389/fphar.2018.01242] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
42 Das UN. Circulating MicroRNAs and Bioactive Lipids in Pre-Eclampsia and Its Cardiovascular Sequelae. Am J Hypertens 2018;31:1079-86. [PMID: 30052752 DOI: 10.1093/ajh/hpy117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
43 El Kholy K, Freire M, Chen T, Van Dyke TE. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. Front Immunol 2018;9:1300. [PMID: 29946319 DOI: 10.3389/fimmu.2018.01300] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
44 Lee JY, Han SH, Park MH, Baek B, Song IS, Choi MK, Takuwa Y, Ryu H, Kim SH, He X, Schuchman EH, Bae JS, Jin HK. Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. Nat Commun 2018;9:1479. [PMID: 29662056 DOI: 10.1038/s41467-018-03674-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
45 Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front Immunol 2018;9:586. [PMID: 29686666 DOI: 10.3389/fimmu.2018.00586] [Cited by in Crossref: 470] [Cited by in F6Publishing: 497] [Article Influence: 94.0] [Reference Citation Analysis]
46 Zhang Z, Hu X, Qi X, Di G, Zhang Y, Wang Q, Zhou Q. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. Mol Vis 2018;24:274-85. [PMID: 29643724] [Reference Citation Analysis]
47 Halade GV, Kain V, Serhan CN. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure. FASEB J 2018;32:3717-29. [PMID: 29455574 DOI: 10.1096/fj.201701173RR] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
48 Zhong X, Lee HN, Surh YJ. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells. Biochem Biophys Res Commun 2018;496:316-23. [PMID: 29305860 DOI: 10.1016/j.bbrc.2017.12.171] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
49 Balta MG, Loos BG, Nicu EA. Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1. Front Immunol 2017;8:1682. [PMID: 29312286 DOI: 10.3389/fimmu.2017.01682] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
50 Sima C, Montero E, Nguyen D, Freire M, Norris P, Serhan CN, Van Dyke TE. ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance. Sci Rep 2017;7:12848. [PMID: 28993702 DOI: 10.1038/s41598-017-13185-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
51 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
52 Yeung J, Hawley M, Holinstat M. The expansive role of oxylipins on platelet biology. J Mol Med (Berl) 2017;95:575-88. [PMID: 28528513 DOI: 10.1007/s00109-017-1542-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 8.7] [Reference Citation Analysis]
53 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 192] [Cited by in F6Publishing: 198] [Article Influence: 32.0] [Reference Citation Analysis]
54 Kourtzelis I, Mitroulis I, von Renesse J, Hajishengallis G, Chavakis T. From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins. J Leukoc Biol 2017;102:677-83. [PMID: 28292945 DOI: 10.1189/jlb.3MR0117-024R] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 11.2] [Reference Citation Analysis]
55 Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA. Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog 2017;56:1977-83. [PMID: 28218420 DOI: 10.1002/mc.22629] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
56 Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273-1288. [PMID: 28087575 DOI: 10.1096/fj.201601222r] [Cited by in Crossref: 346] [Cited by in F6Publishing: 359] [Article Influence: 57.7] [Reference Citation Analysis]
57 Schober M. Docosahexaenoic Acid and Omega 3 Fatty Acids. New Therapeutics for Traumatic Brain Injury 2017. [DOI: 10.1016/b978-0-12-802686-1.00018-3] [Reference Citation Analysis]
58 Jain NG, Wong EA, Aranyosi AJ, Boneschansker L, Markmann JF, Briscoe DM, Irimia D. Microfluidic mazes to characterize T-cell exploration patterns following activation in vitro. Integr Biol (Camb) 2015;7:1423-31. [PMID: 26325525 DOI: 10.1039/c5ib00146c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
59 Meesawatsom P, Burston J, Hathway G, Bennett A, Chapman V. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. J Neuroinflammation 2016;13:233. [PMID: 27589850 DOI: 10.1186/s12974-016-0676-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
60 Polus A, Zapala B, Razny U, Gielicz A, Kiec-Wilk B, Malczewska-Malec M, Sanak M, Childs CE, Calder PC, Dembinska-Kiec A. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim Biophys Acta 2016;1861:1746-55. [PMID: 27531277 DOI: 10.1016/j.bbalip.2016.08.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
61 Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases 2016; 4(7): 155-164 [PMID: 27458590 DOI: 10.12998/wjcc.v4.i7.155] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
62 Das UN. Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome. J Transl Int Med. 2016;4:66-72. [PMID: 28191524 DOI: 10.1515/jtim-2016-0022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
63 Marchenko MM, Ketsa OV, Shmarakov IO, Abutnaritsa KH. Monooxygenase system in Guerin’s carcinoma of rats under conditions of ω-3 polyunsaturated fatty acids administration. Ukr Biochem J 2016;88:48-56. [PMID: 29235764 DOI: 10.15407/ubj88.04.048] [Reference Citation Analysis]
64 Rey C, Nadjar A, Buaud B, Vaysse C, Aubert A, Pallet V, Layé S, Joffre C. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Brain Behav Immun 2016;55:249-59. [PMID: 26718448 DOI: 10.1016/j.bbi.2015.12.013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 93] [Article Influence: 13.0] [Reference Citation Analysis]
65 Wang CS, Wee Y, Yang CH, Melvin JE, Baker OJ. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. Sci Rep 2016;6:24244. [PMID: 27064029 DOI: 10.1038/srep24244] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
66 Martini AC, Berta T, Forner S, Chen G, Bento AF, Ji RR, Rae GA. Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. J Neuroinflammation 2016;13:75. [PMID: 27059991 DOI: 10.1186/s12974-016-0540-8] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 10.9] [Reference Citation Analysis]
67 Harrison JL, Rowe RK, Lifshitz J. Lipid mediators of inflammation in neurological injury: shifting the balance toward resolution. Neural Regen Res 2016;11:77-8. [PMID: 26981087 DOI: 10.4103/1673-5374.175046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
68 Santangelo C, Zicari A, Mandosi E, Scazzocchio B, Mari E, Morano S, Masella R. Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives. Br J Nutr 2016;115:1129-44. [PMID: 26879600 DOI: 10.1017/S0007114516000222] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
69 Reiss CS. Innate Immunity in Viral Encephalitis. Neurotropic Viral Infections 2016. [DOI: 10.1007/978-3-319-33189-8_8] [Reference Citation Analysis]
70 Tarantino G, Finelli C. Lipids, Low-Grade Chronic Inflammation and NAFLD. Handbook of Lipids in Human Function 2016. [DOI: 10.1016/b978-1-63067-036-8.00028-7] [Reference Citation Analysis]
71 Joffre C, Rey C, Nadjar A, Layé S. Role of n-3 PUFAs in inflammationviaresolvin biosynthesis. OCL 2016;23:D104. [DOI: 10.1051/ocl/2015062] [Reference Citation Analysis]
72 Farooqui AA. Effects of Curcumin on Neuroinflammation in Animal Models and in Patients with Alzheimer Disease. Therapeutic Potentials of Curcumin for Alzheimer Disease 2016. [DOI: 10.1007/978-3-319-15889-1_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
73 Qi W, Li H, Cai XH, Gu JQ, Meng J, Xie HQ, Zhang JL, Chen J, Jin XG, Tang Q, Hao Y, Gao Y, Wen AQ, Xue XY, Gao Smith F, Jin SW. Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury. Lab Invest 2015;95:1258-68. [PMID: 26302186 DOI: 10.1038/labinvest.2015.109] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
74 Gu Z, Shan K, Chen H, Chen YQ. n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention. Curr Pharmacol Rep 2015;1:283-94. [PMID: 26457243 DOI: 10.1007/s40495-015-0043-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
75 Mathews JA, Kasahara DI, Ribeiro L, Wurmbrand AP, Ninin FM, Shore SA. γδ T Cells Are Required for M2 Macrophage Polarization and Resolution of Ozone-Induced Pulmonary Inflammation in Mice. PLoS One 2015;10:e0131236. [PMID: 26135595 DOI: 10.1371/journal.pone.0131236] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
76 Harrison JL, Rowe RK, Ellis TW, Yee NS, O'Hara BF, Adelson PD, Lifshitz J. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain Behav Immun 2015;47:131-40. [PMID: 25585137 DOI: 10.1016/j.bbi.2015.01.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 10.5] [Reference Citation Analysis]
77 Sedky Abdou MM, Effat DA, Mansour LA, Abd El Baky NM, Abdul Salam MM. Urinary lipoxin A4 as a biomarker for systemic lupus erythematosus. Egypt Rheumatol Rehabil 2015;42:55-61. [DOI: 10.4103/1110-161x.157861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
78 Pierce A, Pittet JF. Inflammatory response to trauma: implications for coagulation and resuscitation. Curr Opin Anaesthesiol 2014;27:246-52. [PMID: 24419158 DOI: 10.1097/ACO.0000000000000047] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
79 Nakagawa Y, Chiba K. Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) 2014;7:1028-48. [PMID: 25429645 DOI: 10.3390/ph7121028] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 13.4] [Reference Citation Analysis]
80 Corminboeuf O, Leroy X. FPR2/ALXR agonists and the resolution of inflammation. J Med Chem 2015;58:537-59. [PMID: 25365541 DOI: 10.1021/jm501051x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 10.4] [Reference Citation Analysis]
81 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 278] [Cited by in F6Publishing: 293] [Article Influence: 30.9] [Reference Citation Analysis]
82 Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: Connecting inflammation & amp; metabolism. Biochim Biophys Acta. 2015;1851:503-518. [PMID: 25311170 DOI: 10.1016/j.bbalip.2014.09.023] [Cited by in Crossref: 149] [Cited by in F6Publishing: 141] [Article Influence: 16.6] [Reference Citation Analysis]
83 Martini AC, Forner S, Bento AF, Rae GA. Neuroprotective effects of lipoxin A4 in central nervous system pathologies. Biomed Res Int 2014;2014:316204. [PMID: 25276776 DOI: 10.1155/2014/316204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
84 Ferreirós N, Homann J, Labocha S, Grossmann N, Hahn JS, Brüne B, Geisslinger G. Lipoxin A4: Problems with its determination using reversed phase chromatography–tandem mass spectrometry and confirmation with chiral chromatography. Talanta 2014;127:82-7. [DOI: 10.1016/j.talanta.2014.03.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
85 Dmitrieva N, Suess G, Shirley R. Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis. Fertil Steril 2014;102:1191-6. [PMID: 25123641 DOI: 10.1016/j.fertnstert.2014.06.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
86 Bäck M, Powell WS, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol 2014;171:3551-74. [PMID: 24588652 DOI: 10.1111/bph.12665] [Cited by in Crossref: 153] [Cited by in F6Publishing: 155] [Article Influence: 17.0] [Reference Citation Analysis]
87 Wang X, Puerta E, Cedazo-Minguez A, Hjorth E, Schultzberg M. Insufficient resolution response in the hippocampus of a senescence-accelerated mouse model--SAMP8. J Mol Neurosci 2015;55:396-405. [PMID: 24913689 DOI: 10.1007/s12031-014-0346-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
88 Martin CR, Zaman MM, Gilkey C, Salguero MV, Hasturk H, Kantarci A, Van Dyke TE, Freedman SD. Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS One 2014;9:e98773. [PMID: 24892762 DOI: 10.1371/journal.pone.0098773] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
89 Ward PA. The bipolar role of miR-466l in inflammation. Immunity 2013;39:801-2. [PMID: 24238336 DOI: 10.1016/j.immuni.2013.10.014] [Reference Citation Analysis]
90 Griffiths HR, Dias IH, Willetts RS, Devitt A. Redox regulation of protein damage in plasma. Redox Biol 2014;2:430-5. [PMID: 24624332 DOI: 10.1016/j.redox.2014.01.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
91 Kynast KL, Russe OQ, Geisslinger G, Niederberger E. Novel findings in pain processing pathways: implications for miRNAs as future therapeutic targets. Expert Review of Neurotherapeutics 2014;13:515-25. [DOI: 10.1586/ern.13.34] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
92 Farooqui AA. Biochemical Aspects of Neuroinflammation. Inflammation and Oxidative Stress in Neurological Disorders 2014. [DOI: 10.1007/978-3-319-04111-7_2] [Reference Citation Analysis]
93 Zetoune F, Serhan C, Ward P. Inflammatory Disorders☆. Reference Module in Biomedical Sciences 2014. [DOI: 10.1016/b978-0-12-801238-3.05096-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
95 Lee HJ, Park MK, Lee EJ, Lee CH. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. Int J Biochem Cell Biol. 2013;45:2801-2807. [PMID: 24120851 DOI: 10.1016/j.biocel.2013.09.018] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
96 Bruneau S, Nakayama H, Woda CB, Flynn EA, Briscoe DM. DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses. Blood 2013;122:1833-42. [PMID: 23881914 DOI: 10.1182/blood-2013-03-488486] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
97 Jilkova ZM, Hensler M, Medrikova D, Janovska P, Horakova O, Rossmeisl M, Flachs P, Sell H, Eckel J, Kopecky J. Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice. Int J Obes (Lond) 2014;38:216-23. [PMID: 23756677 DOI: 10.1038/ijo.2013.108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
98 Garcia I, Kuska R, Somerman MJ. Expanding the foundation for personalized medicine: implications and challenges for dentistry. J Dent Res 2013;92:3S-10S. [PMID: 23690361 DOI: 10.1177/0022034513487209] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
99 Flachs P, Rossmeisl M, Kuda O, Kopecky J. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: A key to lean phenotype. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013;1831:986-1003. [DOI: 10.1016/j.bbalip.2013.02.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 119] [Article Influence: 10.9] [Reference Citation Analysis]
100 Norling LV, Perretti M. Control of myeloid cell trafficking in resolution. J Innate Immun 2013;5:367-76. [PMID: 23635943 DOI: 10.1159/000350612] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
101 Herter J, Zarbock A. Integrin Regulation during Leukocyte Recruitment. J I 2013;190:4451-7. [DOI: 10.4049/jimmunol.1203179] [Cited by in Crossref: 140] [Cited by in F6Publishing: 143] [Article Influence: 14.0] [Reference Citation Analysis]
102 Das UN. Catechins and osteoporosis. Nutrition 2013;29:697-9. [DOI: 10.1016/j.nut.2012.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]